Search results
What you should know about treating dandruff
Rolling Out· 7 days agoUnderstanding the causes, symptoms, and effective treatments is essential for managing dandruff.
U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio...
Morningstar· 2 days agoApproval supported by two Phase 3 clinical trials that evaluated SKYRIZI® for the treatment of moderate to severe ulcerative colitis: a 12-week induction study, INSPIRE,1 ...
AbbVie stock price forecast: $200 on the cards? | Invezz
Invezz· 17 hours agoThis approval is a significant milestone, making Skyrizi now available for four different conditions in the U.S., including psoriatic arthritis, plaque psoriasis, and Crohn ...
Here Comes the Sun: We Are Your Summer Skincare Experts
Lancaster Online· 1 day agoSummer is finally here and, for most of us, that means more time in the sun - whether it’s relaxing...
Hongkongers told to safeguard against ‘flesh-eating’ bacteria when in Japan
South China Morning Post· 5 days agoAn infection of the “flesh-eating” bacteria Streptococcus pyogenes, or Group A streptococcus, can...
Why Is My Skin So Itchy?
Verywell Health via Yahoo News· 3 days agoPruritus, or itchy skin, is a characteristic feature of many skin diseases and an unusual sign of some systemic diseases. It can be painful or...
Baysient® Launches Therapeutic Drug Monitoring Software for Oncology Biologics
Benzinga· 3 days agoBaysient®, a leading provider of therapeutic drug monitoring (TDM) software, today announced the launch of TuMinimize™, a web-based nomogram/algorithm designed to optimize the dosing of oncology ...
How To Get Rid Of (And Prevent) Chin Acne
Women's Health via Yahoo News· 3 days agoChin acne can be caused by your diet, hygiene practices, hormones, and plenty of other factors. Experts explain how to fight and prevent it in the first...
Nektar Therapeutics (NASDAQ:NKTR) Director Sells $23,400.00 in Stock
ETF DAILY NEWS· 5 days agoNektar Therapeutics (NASDAQ:NKTR – Get Free Report) Director Robert Chess sold 19,500 shares of Nektar Therapeutics stock in a transaction on Friday, June 14th. The shares were sold at an average ...
AbbVie Inc. (NYSE:ABBV) Shares Sold by Garde Capital Inc.
ETF DAILY NEWS· 6 days agoGarde Capital Inc. lowered its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 60.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm ...